Premarket Mover: Cytosorbents Corp (CTSO) Down 4.27%

Cytosorbents Corp (CTSO) is down Monday morning, with the stock declining -4.27% in pre-market trading to 1.57. CTSO's short-term technical score of 4 indicates that the stock has traded less bullishly over the last month than 96% of stocks on the market. In the Medical Devices industry, which ranks 127 out of 146 industries, CTSO ranks higher than 4% of stocks. Cytosorbents Corp has risen 1.23% over the past month, closing at $1.54 on October 10. During this period of time, the stock fell as low as $1.52 and as high as $2.05. CTSO has an average analyst recommendation of Strong Buy. The company has an average price target of $10.13.

CTSO has an Overall Score of 34. Find out what this means to you and get the rest of the rankings on CTSO!

See Full CTSO Report

Cytosorbents Corp has a Long-Term Technical rank of 32. This means that trading over the last 200 trading days has placed the company in the lower half of stocks with 68% of the market scoring higher. In the Medical Devices industry which is number 111 by this metric, CTSO ranks better than 111% of stocks.

Important Dates for Investors in CTSO:

-Cytosorbents Corp is set to release earnings on 2/1/2023. Over the last 12 months, the company has reported EPS of $-0.83. -We do not have a set dividend date for Cytosorbents Corp at this time. Click Here To Get The Full Report on Cytosorbents Corp (CTSO)